220 related articles for article (PubMed ID: 19495761)
1. [Mesenchymal uterine tumors. Leiomyomas].
Lax S
Pathologe; 2009 Jul; 30(4):274-83. PubMed ID: 19495761
[TBL] [Abstract][Full Text] [Related]
2. An immunohistochemical analysis of endometrial stromal and smooth muscle tumors of the uterus: a study of 54 cases emphasizing the importance of using a panel because of overlap in immunoreactivity for individual antibodies.
Oliva E; Young RH; Amin MB; Clement PB
Am J Surg Pathol; 2002 Apr; 26(4):403-12. PubMed ID: 11914617
[TBL] [Abstract][Full Text] [Related]
3. Intraoperative Frozen Section Biopsy of Uterine Smooth Muscle Tumors: A Clinicopathologic Analysis of 112 Cases With Emphasis on Potential Diagnostic Pitfalls.
Lok J; Tse KY; Lee EYP; Wong RWC; Cheng ISY; Chan ANH; Leung CKL; Cheung ANY; Ip PPC
Am J Surg Pathol; 2021 Sep; 45(9):1179-1189. PubMed ID: 34074809
[TBL] [Abstract][Full Text] [Related]
4. Practical issues in uterine pathology from banal to bewildering: the remarkable spectrum of smooth muscle neoplasia.
Oliva E
Mod Pathol; 2016 Jan; 29 Suppl 1():S104-20. PubMed ID: 26715170
[TBL] [Abstract][Full Text] [Related]
5. Uterine smooth muscle tumors other than the ordinary leiomyomas and leiomyosarcomas: a review of selected variants with emphasis on recent advances and unusual morphology that may cause concern for malignancy.
Ip PP; Tse KY; Tam KF
Adv Anat Pathol; 2010 Mar; 17(2):91-112. PubMed ID: 20179432
[TBL] [Abstract][Full Text] [Related]
6. Smooth Muscle Tumors of the Female Genital Tract.
Devereaux KA; Schoolmeester JK
Surg Pathol Clin; 2019 Jun; 12(2):397-455. PubMed ID: 31097110
[TBL] [Abstract][Full Text] [Related]
7. [Smooth muscle neoplasms of the uterus--a 51 cases study].
Wang M; Xu Y; Zhang T
Zhonghua Bing Li Xue Za Zhi; 1996 Oct; 25(5):263-5. PubMed ID: 9388867
[TBL] [Abstract][Full Text] [Related]
8. [Myxoid mesenchymal tumors of uterus: endometrial stromal and smooth muscle tumors, myxoid variant].
Chesnais AL; Watkin E; Beurton D; Devouassoux-Shisheboran M
Ann Pathol; 2011 Jun; 31(3):152-8. PubMed ID: 21736994
[TBL] [Abstract][Full Text] [Related]
9. Pathologic considerations of uterine smooth muscle tumors.
Prayson RA; Hart WR
Obstet Gynecol Clin North Am; 1995 Dec; 22(4):637-57. PubMed ID: 8786875
[TBL] [Abstract][Full Text] [Related]
10. Smooth muscle neoplasms of the urinary bladder: a clinicopathologic comparison of leiomyoma and leiomyosarcoma.
Martin SA; Sears DL; Sebo TJ; Lohse CM; Cheville JC
Am J Surg Pathol; 2002 Mar; 26(3):292-300. PubMed ID: 11859200
[TBL] [Abstract][Full Text] [Related]
11. Epithelioid Leiomyosarcoma of the Uterus: Modern Outcome-based Appraisal of Diagnostic Criteria in a Large Institutional Series.
Chapel DB; Nucci MR; Quade BJ; Parra-Herran C
Am J Surg Pathol; 2022 Apr; 46(4):464-475. PubMed ID: 34419987
[TBL] [Abstract][Full Text] [Related]
12. h-Caldesmon expression effectively distinguishes endometrial stromal tumors from uterine smooth muscle tumors.
Nucci MR; O'Connell JT; Huettner PC; Cviko A; Sun D; Quade BJ
Am J Surg Pathol; 2001 Apr; 25(4):455-63. PubMed ID: 11257619
[TBL] [Abstract][Full Text] [Related]
13. Fascin expression in uterine smooth muscle tumors.
Kefeli M; Yildiz L; Kaya FC; Aydin O; Kandemir B
Int J Gynecol Pathol; 2009 Jul; 28(4):328-33. PubMed ID: 19483633
[TBL] [Abstract][Full Text] [Related]
14. Uterine smooth muscle tumors of uncertain malignant potential and atypical leiomyoma: a morphological study of these grey zones with clinical correlation.
Deodhar KK; Goyal P; Rekhi B; Menon S; Maheshwari A; Kerkar R; Tongaonkar HB
Indian J Pathol Microbiol; 2011; 54(4):706-11. PubMed ID: 22234095
[TBL] [Abstract][Full Text] [Related]
15. Bcl-2 receptor expression in patients with uterine smooth muscle tumors: an immunohistochemical analysis comparing leiomyoma, uterine smooth muscle tumor of uncertain malignant potential, and leiomyosarcoma.
Bodner K; Bodner-Adler B; Kimberger O; Czerwenka K; Mayerhofer K
J Soc Gynecol Investig; 2004 Apr; 11(3):187-91. PubMed ID: 15051039
[TBL] [Abstract][Full Text] [Related]
16. [Histological diagnosis and clinical features in borderline smooth muscle tumors of the uterus].
Shi YF; Xie X; Zhao CL
Zhonghua Fu Chan Ke Za Zhi; 1994 Apr; 29(4):201-4, 251. PubMed ID: 8082439
[TBL] [Abstract][Full Text] [Related]
17. Differential expression of P16 and P21 in benign and malignant uterine smooth muscle tumors.
Ünver NU; Acikalin MF; Öner Ü; Ciftci E; Ozalp SS; Colak E
Arch Gynecol Obstet; 2011 Aug; 284(2):483-90. PubMed ID: 20878171
[TBL] [Abstract][Full Text] [Related]
18. Smooth muscle tumors of the ovary: a clinicopathologic study of 54 cases emphasizing prognostic criteria, histologic variants, and differential diagnosis.
Lerwill MF; Sung R; Oliva E; Prat J; Young RH
Am J Surg Pathol; 2004 Nov; 28(11):1436-51. PubMed ID: 15489647
[TBL] [Abstract][Full Text] [Related]
19. Uterine leiomyosarcomas are characterized by high p16, p53 and MIB1 expression in comparison with usual leiomyomas, leiomyoma variants and smooth muscle tumours of uncertain malignant potential.
O'Neill CJ; McBride HA; Connolly LE; McCluggage WG
Histopathology; 2007 Jun; 50(7):851-8. PubMed ID: 17543074
[TBL] [Abstract][Full Text] [Related]
20. [Practical diagnostic aspects of uterine leiomyosarcoma in the context of the 2020 WHO classification].
Horn LC; Hiller GGR; Mayr D; Schmoeckel E; Höhn AK
Pathologe; 2022 May; 43(3):196-201. PubMed ID: 35412039
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]